On Tuesday, Twist Bioscience Corp (NASDAQ: TWST) was -0.82% drop from the session before settling in for the closing price of $39.26. A 52-week range for TWST has been $27.41 – $60.90.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 42.89% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 43.45%. With a float of $56.37 million, this company’s outstanding shares have now reached $59.58 million.
In an organization with 923 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 44.59%, operating margin of -63.15%, and the pretax margin is -59.59%.
Twist Bioscience Corp (TWST) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Twist Bioscience Corp stocks. The insider ownership of Twist Bioscience Corp is 5.50%, while institutional ownership is 107.00%. The most recent insider transaction that took place on Mar 20 ’25, was worth 9,585. In this transaction an insider of this company sold 230 shares at a rate of $41.68, taking the stock ownership to the 111,662 shares. Before that another transaction happened on Mar 20 ’25, when Company’s SVP of Human Resources sold 291 for $41.68, making the entire transaction worth $12,128. This insider now owns 130,621 shares in total.
Twist Bioscience Corp (TWST) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.55 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 43.45% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 37.54% during the next five years compared to 1.70% growth over the previous five years of trading.
Twist Bioscience Corp (NASDAQ: TWST) Trading Performance Indicators
You can see what Twist Bioscience Corp (TWST) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.62. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.38, a number that is poised to hit -0.55 in the next quarter and is forecasted to reach -1.50 in one year’s time.
Technical Analysis of Twist Bioscience Corp (TWST)
Let’s dig in a bit further. During the last 5-days, its volume was 0.88 million. That was inferior than the volume of 0.98 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 19.88%. Additionally, its Average True Range was 2.96.
During the past 100 days, Twist Bioscience Corp’s (TWST) raw stochastic average was set at 21.88%, which indicates a significant decrease from 22.39% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 50.33% in the past 14 days, which was lower than the 64.30% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $44.81, while its 200-day Moving Average is $46.10. However, in the short run, Twist Bioscience Corp’s stock first resistance to watch stands at $40.68. Second resistance stands at $42.41. The third major resistance level sits at $44.03. If the price goes on to break the first support level at $37.32, it is likely to go to the next support level at $35.70. Assuming the price breaks the second support level, the third support level stands at $33.97.
Twist Bioscience Corp (NASDAQ: TWST) Key Stats
There are 59,651K outstanding shares of the company, which has a market capitalization of 2.32 billion. As of now, sales total 312,970 K while income totals -208,730 K. Its latest quarter income was 88,710 K while its last quarter net income were -31,590 K.
